PROPANC BIOPHARMA, INC. Other Comprehensive Income (Loss), before Reclassifications, Net of Tax
PROPANC BIOPHARMA, INC. (PPCB) reported Other Comprehensive Income (Loss), before Reclassifications, Net of Tax of $349.80 thousand for the 9-month period ending 2015-03-31, per its 10-Q filed 2015-05-15.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax · last filed 2015-05-15
- PROPANC BIOPHARMA, INC. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2015-03-31 was $131.66K.
- PROPANC BIOPHARMA, INC. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2014-12-31 was $103.32K.
- PROPANC BIOPHARMA, INC. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2014-09-30 was $114.82K.
- PROPANC BIOPHARMA, INC. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2014 was -$58.27K, a 150.97% decline from fiscal 2013.
- PROPANC BIOPHARMA, INC. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2013 was $114.33K.
| Period end | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 3 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 6 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 9 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 12 month |
|---|---|---|---|---|
| 2015-03-31 | $131.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | $234.98K derived: sum of 2 quarters · filed 2015-05-15 | $349.80K 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $103.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-17 | $218.14K 10-Q · filed 2015-02-17 | ||
| 2014-09-30 | $114.82K 10-Q · filed 2014-11-19 | |||
| 2014-06-30 | -$58.27K 10-K · filed 2014-10-14 | |||
| 2013-06-30 | $114.33K 10-K · filed 2014-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |